Literature DB >> 18506697

Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage.

Cristiana Gambelunghe1, Kyriaki Aroni, Riccardo Rossi, Luca Moretti, Mauro Bacci.   

Abstract

Recently many people have shown great interest in traditional indigenous practices and popular medicine, involving the ingestion of natural psychotropic drugs. We received a request to analyze and determine the nature of a dark green liquid with a dark brown plant sediment, which the police had seized at an airport and inside the home of a person belonging to the 'Santo Daime' religious movement. Gas chromatography/mass spectrometry analysis of the extract identified N,N-dimethyltryptamine, a potent hallucinogen, and the beta-carboline alkaloids harmine and harmaline, revealing monoamine oxidase A-inhibiting properties. These substances are typical components of Ayahuasca, a South American psychotropic beverage obtained by boiling the bark of the liana Banisteriopsis caapi together with the leaves of various admixture plants, principally Psychotria viridis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506697     DOI: 10.1002/bmc.1023

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  9 in total

1.  Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice.

Authors:  J C Winter; D J Amorosi; Kenner C Rice; Kejun Cheng; Ai-Ming Yu
Journal:  Pharmacol Biochem Behav       Date:  2011-05-23       Impact factor: 3.533

Review 2.  Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Jerrold C Winter; Ai-Ming Yu
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

Review 3.  When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.

Authors:  Tsung-Ping Su; Teruo Hayashi; D Bruce Vaupel
Journal:  Sci Signal       Date:  2009-03-10       Impact factor: 8.192

Review 4.  Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?

Authors:  Breland Smith; Federico Medda; Vijay Gokhale; Travis Dunckley; Christopher Hulme
Journal:  ACS Chem Neurosci       Date:  2012-08-28       Impact factor: 4.418

Review 5.  Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.

Authors:  Thomas S Guillot; Gary W Miller
Journal:  Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.590

Review 6.  Sigma Receptors and Substance Use Disorders.

Authors:  Valentina Sabino; Callum Hicks; Pietro Cottone
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 3.650

7.  Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples.

Authors:  Gabriela de Oliveira Silveira; Rafael Guimarães Dos Santos; Felipe Rebello Lourenço; Giordano Novak Rossi; Jaime E C Hallak; Mauricio Yonamine
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

8.  New Insights into the Chemical Composition of Ayahuasca.

Authors:  Luisina Rodríguez; Andrés López; Guillermo Moyna; Gustavo A Seoane; Danilo Davyt; Álvaro Vázquez; Gonzalo Hernández; Ignacio Carrera
Journal:  ACS Omega       Date:  2022-04-01

9.  Detection and Quantification of Psychoactive N,N-Dimethyltryptamine in Ayahuasca Brews by Ambient Ionization High-Resolution Mass Spectrometry.

Authors:  Megan I Chambers; Meghan G Appley; Cameron M Longo; Rabi A Musah
Journal:  ACS Omega       Date:  2020-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.